Pragmatic and Observational Research
Volume 11, 2020 - Issue
Original Research
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States
Lisa M Hess1 Global Patient Outcomes, Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
https://orcid.org/0000-0003-3631-3941View further author information
https://orcid.org/0000-0003-3631-3941View further author information, Michael Grabner2 Life Sciences Research, HealthCore Inc., Wilmington, DE, USAhttps://orcid.org/0000-0002-6521-1007View further author information
https://orcid.org/0000-0002-6521-1007View further author information, , Astra M Liepa1 Global Patient Outcomes, Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0002-1395-2831View further author information
https://orcid.org/0000-0002-1395-2831View further author information, , Zhanglin Lin Cui3 Global Statistics, Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0002-7034-0946View further author information
https://orcid.org/0000-0002-7034-0946View further author information, Lee Bowman1 Global Patient Outcomes, Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0003-4590-2262View further author information
https://orcid.org/0000-0003-4590-2262View further author information & show all